SEARCH

SEARCH BY CITATION

References

  • 1
    Michalek SM, Eldridge JH, Curtis R III, Rosenthal KL. Antigen delivery systems: new approaches to mucosal immunization. In: Ogra PL, Lamm ME, McGhee JR, Mestecky J, Strober W, Bienestock J, eds. Handbook of Mucosal Immunology. New York: Academic Press, 1994:373 6.
  • 2
    Elson CO & Dertzbaugh MT. Mucosal adjuvants. In: Ogra PL, Lamm ME, McGhee JR, Mestecky J, Strober W, Bienestock J, eds. Handbook of Mucosal Immunology. New York: Academic Press, 1994:391 401.
  • 3
    Clements JD, Hartzog NM, Lyon FL. Adjuvant activity of Escherichia coli heat labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine 1988; 6:269 77.
  • 4
    Lycke N & Holmgren J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunol 1986;59:301 8.
  • 5
    Lycke N, Karlsson A, Sjôlander A, Magnusson KE. The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens. Scand J Immunol 1991;33:691 8.
  • 6
    Bromader A, Holmgren J, Lycke N. Cholera toxin stimulates IL-1 production and enhanced antigen presentation by macrophages in vitro. J Immunol 1991;146:2908 14.
  • 7
    Elson CO, Holland S, Woogen S. Preferential inhibition of the CD4+ T cell subset by cholera toxin (CT) and its B Subunit (CT-B). FASEB J 1990;4:A1864.
  • 8
    Spangler BD. Structure and function of cholera toxin and related Escherichia coli heat labile enterotoxin. Microbiol Rev 1992; 46:622 47.
  • 9
    Yamamoto S, Kiyono H, Yamamoto M et al A nontoxic mutant of cholera toxin elicits Th2-type response for enhanced mucosal immunity. Proc Natl Acad Sci USA 1997;94:5267 72.
  • 10
    Dickinson BL & Clements JD. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticitiy from ADP-ribosyltransferase activity. Infect Immun 1995;63:1617 23.
  • 11
    Höfte H & Whiteley H. Insecticidal crystal proteins of Bacillus thuringiensis. Microbiol Rev 1989;53:242 55.
  • 12
    Ge AZ, Pfister RM, Dean DH. Hyperexpression of a Bacillus thuringiensis delta-endotoxin-encoding gene in Escherichia coli: properties of the product. Gene 1990;93:49 54.
  • 13
    Vázquez-Padrón RI, Moreno-Fierros L, Neri-Bazan L, de la Riva GA, Lopez-Revilla R. Intragastric and intraperitoneal administration of Cry1Ac protoxin from Bacillus thuringiensis induces systemic and mucosal antibody responses in mice. Life Sci 1999;64:1897 1972.
  • 14
    Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680 5.
  • 15
    Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248 54.
  • 16
    Moreno-Fierros L, Domínguez-Robles MA, Enríquez-Rincón F. Entamoeba histolytica: induction and isotype analysis of antibody producing cell responses in Peyer's patches and spleen after local and systemic immunization in male and female mice. Exp Parasitol 1995;80:541 9.
  • 17
    Hornbeck P. Indirect ELISA to detect specific antibodies. In: Coligan JE, Kruisbeek AM, Margulies DH, Saevach ET, Struber W, eds. Current Protocols in Immunology. New York: Wiley, 1996:2.1.3 6.
  • 18
    Knowles B. Mechanism of action of Bacillus thuringiensis insecticidal delta-endotoxin. Adv Insect Physiol 1994;24:275 3076.
  • 19
    Herrera G, Snyman S, Thompson J. Construction of a bioinsecticidal strain of Pseudomonas fluorescens active against the sugarcane borer, Eldana saccharina. Appl Environ Microbiol 1994;60:682 90.
  • 20
    Perlak FJ, Deaton RW, Armstrong TA et al Insect resistant cotton plants. Biotechnol 1990;8:939.
  • 21
    Carlson CR, Caugant DA, Kolsto AB. Genotypic diversity among Bacillus thuringiensis and Bacillus cereus strains. Appl Environ Microbiol 1994;60:1719 25.
  • 22
    Vázquez RI, de Prieto D, la Riva G, Selman-Housein G. Development of an immunoradiometric assay for quantitative determination of CryIA (b) protein in transgenic sugarcane plants. J Immunol Meth 1996;196:33 9.
  • 23
    Prasad SSSV & Shethna YI. Antitumor immunity against YAS after treatment with proteinaceous crystals of Bacillus thuringiensis. Indian J Exp Biol 1976;14:285 90.
  • 24
    Prasad SSSV & Shethna YI. Enhancement of immune response by the proteinaceous crystal of Bacillus thuringiensis. Biochim Biophys Res Commun 1975;62:517 21.
  • 25
    Wilson AD, Clarke CJ, Stokes CR. Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin. Scand J Immunol 1990;31:443 51.
  • 26
    Wilson AD, Stokes CR, Bourne FJ. Adjuvant effect of cholera toxin on the mucosal immune response to soluble proteins. Scand J Immunol 1989;29:739 45.
  • 27
    Hopkins S, Krahenbuhl J-P, Schödel F et al A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect Immun 1995;63:3279 86.
  • 28
    Milich DR, McLachlan A, Thornton GB, Hughes JL. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature 1987;329: 547 9.
  • 29
    McClintock JT, Schaffer CR, Sjoblad RD. A comparative review of the mammalian toxicity of Bacillus thuringiensis-based pesticides. Pestic Sci 1995;45:95 105.